Loading…

Rethinking Combination Therapy for S. aureus bacteremia: A Fading Paradigm

Staphylococcus aureus bacteremia presents clinical complexities, with prolonged duration associated with unfavorable outcomes. This research delves into unconventional treatments, such as combinations involving daptomycin, oxacillin, ceftaroline, and fosfomycin, with the aim of swiftly sterilizing b...

Full description

Saved in:
Bibliographic Details
Published in:The New microbiologica 2024-07, Vol.47 (2), p.183
Main Authors: Venturini, Sergio, Reffo, Ingrid, Avolio, Manuela, Basaglia, Giancarlo, Del Fabro, Giovanni, Callegari, Astrid, Bramuzzo, Igor, Tonizzo, Maurizio, Lucis, Riccardo, Pontoni, Elisa, De Santi, Laura, Crapis, Massimo
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Staphylococcus aureus bacteremia presents clinical complexities, with prolonged duration associated with unfavorable outcomes. This research delves into unconventional treatments, such as combinations involving daptomycin, oxacillin, ceftaroline, and fosfomycin, with the aim of swiftly sterilizing bloodstream infection to reduce complications. Our examination of 30 MSSA bacteremia patients with infective endocarditis uncovers differing results between single-agent therapies (oxacillin or daptomycin) and combined treatment plans. Microbiologic clearance at the 72 hour mark demonstrates greater efficacy within the combination cohort (bacteremia persistence 29%) versus monotherapy (bacteremia persistence 78%). This limited case series suggests the potential superiority of combination therapy, prompting further investigations.
ISSN:1121-7138